Ohlhausen says Steris-Synergy decision should give FTC pause when considering potential competition cases
The victory of Steris and Synergy Health in a court fight with the US Federal Trade Commission over the companies’ proposed merger should cause the agency to be careful in pursuing...To view the full article, register now.
Already a subscriber? Click here to view full article